Which has the lower trailing P/E, DVA or GMED?

DVA has the lower trailing P/E: DVA trades at 15.82 and GMED at 21.22. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DVA or GMED?

Over the past five years, GMED grew revenue faster — DVA at a 3.91% CAGR versus GMED at 27.65%.

Is DVA or GMED more profitable?

GMED runs the higher net margin — DVA at 6.05% versus GMED at 17.03%.

How have DVA and GMED total returns compared?

Over the past 10 years, DVA delivered 10.95% and GMED delivered 13.76% annualized total return. Past performance doesn't predict future results.

DaVita Inc. (DVA) vs Globus Medical, Inc. (GMED)

A side-by-side comparison of DaVita Inc. and Globus Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.

DVA

DaVita Inc.

$11.48B

$178.88HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

GMED

Globus Medical, Inc.

$11.13B

$82.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — DVA vs GMED

growth of $100 · dividends reinvested · last 10y

DVA +179.2% (+10.8%/yr)GMED +264.3% (+13.8%/yr)GMED compounded faster over this window

DVA GMED

DVA vs GMED: by the numbers

•DVA is the larger company ($11.48B vs $11.13B market cap).
•DVA trades at the lower trailing earnings multiple (15.82 vs 21.22 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 6.05% net margin).
•GMED grew revenue faster over the past five years (27.65% vs 3.91% CAGR).

Metrics side by side

Valuation

Metric	DVA	GMED
P/E ratio	15.82	21.22
Forward P/E	12.13	16.57
P/S ratio	0.85	3.63
P/B ratio	N/A	2.39
EV / EBITDA	7.81	11.79
FCF yield	13.53%	6.58%

Profitability

Metric	DVA	GMED
Gross margin	31.02%	68.55%
Operating margin	15.06%	20.75%
Net margin	6.05%	17.03%
ROE	-114.70%	11.23%
ROIC	11.18%	10.49%

Growth (annualized)

Metric	DVA	GMED
Revenue CAGR (5Y)	3.91%	27.65%
EPS CAGR (5Y)	8.25%	30.79%
FCF CAGR (5Y)	7.44%	29.93%
Total return CAGR (5Y)	6.74%	0.22%

Frequently asked

Which has the lower trailing P/E, DVA or GMED?: DVA has the lower trailing P/E: DVA trades at 15.82 and GMED at 21.22. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DVA or GMED?: Over the past five years, GMED grew revenue faster — DVA at a 3.91% CAGR versus GMED at 27.65%.
Is DVA or GMED more profitable?: GMED runs the higher net margin — DVA at 6.05% versus GMED at 17.03%.
How have DVA and GMED total returns compared?: Over the past 10 years, DVA delivered 10.95% and GMED delivered 13.76% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DVA analysis Full GMED analysis Interactive comparison tool

Dig into the metrics

DaVita P/E ratio Globus Medical P/E ratio DaVita ROE Globus Medical ROE DaVita operating margin Globus Medical operating margin DaVita revenue growth Globus Medical revenue growth DaVita free cash flow Globus Medical free cash flow

DaVita & Globus Medical appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.